Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457755 · ClinicalTrials.gov registry record
Gilead Sustained Virologic Response (SVR) Registry
A clinical trial, sponsored by Gilead Sciences.
- Completed
- Registry status
- 6,625
- Enrollment target
NCT01457755: Completed study, sponsored by Gilead Sciences.
NCT01457755 is a clinical trial that has completed, run by Gilead Sciences. The registered enrollment target is 6,625 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457755 has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 6,625 participants
- Enrollment target
Study Summary
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,625 participants |
| Start Date | 2012-04-13 |
| Est. Completion | 2018-01-08 |
What the finished NCT01457755 record still lists
NCT01457755 is an observational study that tracks outcomes without assigning an intervention. Its 6,625 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01457755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01457755 about?
NCT01457755 is a clinical study titled "Gilead Sustained Virologic Response (SVR) Registry". This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is p...
What is the current status of trial NCT01457755?
This trial is currently completed. The enrollment target is 6,625 participants. The study started on 2012-04-13. Estimated completion is 2018-01-08.
Who is sponsoring clinical trial NCT01457755?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI